|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.31 EUR | +1.35% |
|
+1.13% | -8.96% |
| 08-07 | SANOFI : Gets a Buy rating from Jefferies | ZD |
| 08-06 | Novavax raises annual revenue forecast as licensing bets offset weak vaccine demand | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 104B | |||||
| 1,057B | |||||
| 625B | - | - | - | ||
| 435B | |||||
| 363B | |||||
| 296B |
- Stock Market
- Stocks
- SAN Stock
- Charts Sanofi
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
